.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Rise (MI) is stocked at 305 licensed dispensaries across Michigan, with the deepest coverage in New Buffalo, Detroit, Lansing, Monroe, and Ann Arbor. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Rise (MI) concentrated 40.93% of July 2026 sales in Concentrates with a year-over-year decline of 16.88% and a month-over-month drop of 3.36%, while Topical held 31.40% share with a 36.99% YoY decline but a 23.01% MoM rebound; Tincture & Sublingual accounted for 13.83% share with a 61.58% YoY slide and a 10.82% MoM dip, and Capsules at 13.78% share fell 27.11% YoY and 7.49% MoM. Against a brand-level sales decline of 35.06% YoY and an average price up 3.82% YoY to $16.43, the heavier exposure to faster-declining wellness formats (Tincture & Sublingual at -61.58% YoY) versus the relatively less-negative Concentrates (-16.88% YoY) implies mix pressure is amplifying the topline contraction, even as the state focus in MI centers demand in a single market.
With Concentrates leading share yet paired with a category rank of 40 in Michigan and a 3.36% MoM dip, while Topical surged 23.01% MoM but still sits 36.99% below last year, the portfolio is tethered to categories that either carry mid-pack positioning or volatile recovery paths. The mix skews toward need-state segments with steep YoY drops (down 27.11% to 61.58%) and away from growth pockets, which suggests July 2026 positioning is defensive: sustaining relevance in Concentrates despite a rank of 40, while relying on a Topical MoM bounce to stabilize share rather than to drive expansion.
Competitive Landscape
Rise (MI) sits at rank #40 in July 2026, down 8 places year over year from #32, but up 19 positions versus April 2026 when it was #59; this volatility contrasts with Rkive Cannabis advancing to #1 from #5 with 150.2% YoY sales growth, and Uniq Pressure vaulting to #3 from #145 alongside 9,866.4% YoY growth. Against this backdrop, Cannalicious Labs moved to #5 from #2 despite a 29.6% YoY sales decline, while The Limit edged down to #2 from #1 with a 1.7% YoY dip; the combination of a current #40 rank and a prior peak of #21 in December 2024 indicates that Rise (MI) is losing share to faster-moving rivals and must convert recent quarter-on-quarter rank recovery into sustained gains.
Notable Products
Hybrid RSO (1g) posted the largest month-over-month gain at 88.8% while climbing into rank 5, as Hybrid RSO Dart (1g) fell 37.7% yet held rank 1. Maui Wowie RSO Syringe (1g) advanced 53.6% to rank 2, and together with four other Concentrates in the top ten this concentration signals a tilt toward RSO-led inhalable formats over slower-growing Topicals. The presence of two Topicals in ranks 3 and 4 alongside a 39.1% lift for Unscented RSO Cream (3000mg THC, 3oz) and only a 4.8% rise for Unscented RSO Cream (1000mg THC, 1oz) implies up-trading to higher-potency formats.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
